Understanding Tepezza Lawsuits
FDA warnings, hearing damage, and compensation claims
2026 Tepezza Lawsuit Statistics
20K
Affected
1.5K
Lawsuits
$450,000
Avg Value
65%
Affected Rate
Hearing Injuries & Avg Settlements
| Injury Type | Avg Settlement |
|---|---|
Permanent Hearing Loss Complete or severe hearing damage | $800,000 |
Partial Hearing Loss Moderate hearing impairment | $400,000 |
Severe Tinnitus Constant ringing in ears | $300,000 |
Hyperacusis Painful sound sensitivity | $250,000 |
Mild Hearing Impairment Slight hearing reduction | $150,000 |
Combined Hearing/Tinnitus Multiple hearing symptoms | $600,000 |
Infusion Impact
- • 1-4 infusions: 0.7x base settlement
- • 5-8 infusions (full course): 1x base settlement
- • 8+ infusions: 1.3x base settlement
- • Multiple treatment courses: 1.5x base settlement
Treated Conditions
- • Thyroid Eye Disease (TED)
- • Graves' Disease
- • Graves' Ophthalmopathy
Advertisement
Based on official MDL 3079 court filings, FDA label warning updates (July 2023), and 2026 Audiology clinical research on IGF-1R inhibitor ototoxicity.